{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T21:51:28Z","timestamp":1787435488315,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ymgme.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:53:01Z","timestamp":1550231581000},"page":"23-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Ophthalmological findings in Gaucher disease"],"prefix":"10.1016","volume":"127","author":[{"given":"Areian","family":"Eghbali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzeb","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Seehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"FitzGibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2019.02.002_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/diseases5010010","article-title":"The spectrum of neurological manifestations associated with Gaucher disease","volume":"5","author":"Roshan Lal","year":"2017","journal-title":"Diseases"},{"issue":"6","key":"10.1016\/j.ymgme.2019.02.002_bb0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00006982-199919060-00019","article-title":"Preretinal white dots in adult-type Gaucher disease","volume":"19","author":"Wollstein","year":"1999","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ymgme.2019.02.002_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/01658107.2017.1420084","article-title":"Photo essay: retinal changes in type 3 Gaucher disease","volume":"42","author":"Anand","year":"2018","journal-title":"Neuroophthalmology"},{"issue":"8","key":"10.1016\/j.ymgme.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaophthalmol.2013.7817","article-title":"Preretinal and posterior vitreous deposits in Gaucher disease","volume":"132","author":"Hsing","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ymgme.2019.02.002_bb0025","series-title":"Advances in vision research, Volume I: Genetic Eye Research in Asia and the Pacific","first-page":"413","article-title":"Ocular implications of Gaucher disease","author":"Abu-Asab","year":"2017"},{"issue":"2","key":"10.1016\/j.ymgme.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10633-008-9142-9","article-title":"Functional retinal changes in Gaucher disease","volume":"118","author":"Seidova","year":"2009","journal-title":"Doc. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.02.002_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchromb.2004.02.027","article-title":"Evaluation of sphingolipids in vitreous bodies from a patient with Gaucher disease, using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"806","author":"Fujiwaki","year":"2004","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"9","key":"10.1016\/j.ymgme.2019.02.002_bb0040","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archopht.122.9.1395","article-title":"Vitreous opacities and retinal vascular abnormalities in Gaucher disease","volume":"122","author":"Shrier","year":"2004","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.02.002_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2013.04.001","article-title":"Retinal thinning in Gaucher disease patients and carriers: results of a pilot study","volume":"109","author":"McNeill","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2019.02.002_bb0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0002-9394(98)00249-9","article-title":"Corneal opacities in Gaucher disease","volume":"126","author":"Guemes","year":"1998","journal-title":"Am J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ymgme.2019.02.002_bb0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0404.1992.tb05109.x","article-title":"Hydrocephalus, corneal opacities, deafness, valvular heart disease, deformed toes and leptomeningeal fibrous thickening in adult siblings: a new syndrome associated with beta-glucocerebrosidase deficiency and a mosaic population of storage cells","volume":"86","author":"Uyama","year":"1992","journal-title":"Acta Neurol. Scand."},{"issue":"8981","key":"10.1016\/j.ymgme.2019.02.002_bb0060","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(95)91688-1","article-title":"Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype","volume":"346","author":"Abrahamov","year":"1995","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ymgme.2019.02.002_bb0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jmg.32.9.740","article-title":"Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation","volume":"32","author":"Chabas","year":"1995","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2019.02.002_bb0070","first-page":"211","article-title":"Hydrocephalus, corneal opacities, deafness, left ventricle hypertrophy, clinodactyly in an adolescent patient. A new syndrome associated with glucocerebrosidase deficiency","volume":"6","author":"Erduran","year":"1995","journal-title":"Genet. Couns."},{"issue":"2","key":"10.1016\/j.ymgme.2019.02.002_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/112067219500500201","article-title":"Morphological and biochemical assessment of the cornea in a Gaucher disease carrier with keratoconus","volume":"5","author":"Salgado-Borges","year":"1995","journal-title":"Eur. J. Ophthalmol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2019.02.002_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09273949309086547","article-title":"Chronic uveitis in Gaucher's disease","volume":"1","author":"Raz","year":"1993","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"6","key":"10.1016\/j.ymgme.2019.02.002_bb0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-2008-1035003","article-title":"Uveitis masquerade syndrome in Gaucher disease. Causal treatment by alglucerase substitution therapy","volume":"213","author":"Dann","year":"1998","journal-title":"Klin. Monatsbl. Augenheilkd."},{"issue":"20","key":"10.1016\/j.ymgme.2019.02.002_bb0090","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199805143382016","article-title":"Loss of vision in Gaucher's disease and its reversal by enzyme-replacement therapy","volume":"338","author":"vom Dahl","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2019.02.002_bb0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajo.2004.12.081","article-title":"Uveitis in Gaucher disease","volume":"140","author":"Dweck","year":"2005","journal-title":"Am J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.02.002_bb0100","first-page":"3","article-title":"Type I Gaucher's disease: clinical, evolutive and therapeutic features in 8 cases","volume":"vol. 39","author":"Giraldo","year":"1994","journal-title":"Sangre (Barc)"},{"issue":"6","key":"10.1016\/j.ymgme.2019.02.002_bb0105","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-9394(75)90329-3","article-title":"Ocular manifestations of Gaucher's disease","volume":"80","author":"Petrohelos","year":"1975","journal-title":"Am J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13816818409009887","article-title":"The pathology of pingueculae in Gaucher's disease","volume":"4","author":"Chu","year":"1984","journal-title":"Ophthalmic Paediatr Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2019.02.002_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bjo.80.2.151","article-title":"Intermittent horizontal saccade failure ('ocular motor apraxia') in children","volume":"80","author":"Harris","year":"1996","journal-title":"Br. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.ymgme.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.43.10.1993","article-title":"Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2019.02.002_bb0125","series-title":"Manual of Neuro-Ophthalmology","author":"Agarwal","year":"2015"},{"key":"10.1016\/j.ymgme.2019.02.002_bb0130","series-title":"Review of Clinical and Functional Neuroscience","author":"Swenson","year":"2006"},{"issue":"7","key":"10.1016\/j.ymgme.2019.02.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022410","article-title":"The saccadic and neurological deficits in type 3 Gaucher disease","volume":"6","author":"Benko","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2019.02.002_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fneur.2017.00295","article-title":"Saccadic impairments in patients with the Norrbottnian Form of Gaucher's disease Type 3","volume":"vol. 8","author":"Blume","year":"2017","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.ymgme.2019.02.002_bb0145","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0042-6989(78)90218-3","article-title":"Primary and secondary saccades to goals defined by instructions","volume":"18","author":"Hallett","year":"1978","journal-title":"Vis. Res."},{"key":"10.1016\/j.ymgme.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fneur.2017.00711","article-title":"Oculomotor and vestibular findings in Gaucher disease type 3 and their correlation with neurological findings","volume":"8","author":"Bremova-Ertl","year":"2017","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2019.02.002_bb0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2007-973507","article-title":"Ocular motor abnormalities in Gaucher disease","volume":"30","author":"Harris","year":"1999","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.ymgme.2019.02.002_bb0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.pediatrneurol.2014.10.016","article-title":"Oculomotor apraxia in Gaucher disease","volume":"52","author":"Nagappa","year":"2015","journal-title":"Pediatr. Neurol."},{"issue":"11","key":"10.1016\/j.ymgme.2019.02.002_bb0165","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1212\/WNL.57.11.2070","article-title":"Pathophysiology of slow vertical saccades in progressive supranuclear palsy","volume":"57","author":"Bhidayasiri","year":"2001","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2019.02.002_bb0170","doi-asserted-by":"crossref","first-page":"S542","DOI":"10.1007\/s00415-014-7385-9","article-title":"Central ocular motor disorders, including gaze palsy and nystagmus","volume":"261","author":"Strupp","year":"2014","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2019.02.002_bb0175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4103\/0301-4738.133482","article-title":"Saccadic eye movements in Parkinson's disease","volume":"62","author":"Srivastava","year":"2014","journal-title":"Indian J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.02.002_bb0180","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1212\/NXG.0000000000000057","article-title":"Clinical course and prognosis in patients with Gaucher disease and parkinsonism","volume":"2","author":"Lopez","year":"2016","journal-title":"Neurol. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2019.02.002_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcmd.2010.08.012","article-title":"Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity","volume":"46","author":"Gupta","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2019.02.002_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","article-title":"The clinical management of type 2 Gaucher disease","volume":"114","author":"Weiss","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2019.02.002_bb0195","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJMcp051888","article-title":"Pediatric Strabismus","volume":"356","author":"Donahue","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2019.02.002_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13816810.2016.1193878","article-title":"A case of traction retinal detachment in a patient with Gaucher disease","volume":"38","author":"Watanabe","year":"2017","journal-title":"Ophthalmic Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2019.02.002_bb0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/2474126418780761","article-title":"Bilateral pars Plana vitrectomy for vitreous opacities and Epiretinal membrane in Gaucher disease","volume":"2","author":"Storey","year":"2018","journal-title":"J. VitreoRetinal Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2019.02.002_bb0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/03009734.2016.1158756","article-title":"The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy","volume":"121","author":"Sawicka-Gutaj","year":"2016","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.ymgme.2019.02.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/358534","article-title":"Eye movement impairment recovery in a Gaucher patient treated with miglustat","volume":"2010","author":"Accardo","year":"2010","journal-title":"Neurol. Res. Int."},{"issue":"5","key":"10.1016\/j.ymgme.2019.02.002_bb0220","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher's disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann. Neurol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219300733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219300733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:23:49Z","timestamp":1761089029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219300733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1096719219300733"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.02.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophthalmological findings in Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}